Health Trials

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

ConditionsProgressionPostoperative Recovery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-75
SponsorShanghai Zhongshan Hospital

About this trial

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1

Eligibility criteria

Qualifiers

1.Aged between 25 and 75 years;

2. GGO is diagnosed by thin-section lung CT (thickness <1.5mm) within one month before surgery;

3. The maximum diameter of the GGO is smaller than 3cm;

4. The solid component in GGO between 50%-100%;

Disqualifiers

1. Patients with a history of lung surgery;

2. Postoperative pathology showed non-primary lung cancer;

3. The scope of surgical resection is larger than one lung lobe;

4. Patients with a history of other tumors;

Trial design

Treatments tested in this trial

  • selective lymph node dissection
  • Systemic Lymph Node Dissection

Treatment groups

500 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Shanghai Zhongshan Hospital

Lead sponsor

Source ClinicalTrials.gov